Evidence map›Paper›PMID 39578734›Full record

ArticleBMC genomics2024

Whole genome sequencing-based characterization and determination of quinolone resistance among methicillin-resistant and methicillin-susceptible S. Aureus isolates from patients attending regional referral hospitals in Tanzania.

Masoud A Juma, Happiness Kumburu, Boaz Wadugu, Davis Kuchaka, Mariana Shayo, Patrick Kimu, Livin E Kanje, Melkiory Beti, Marco van Zwetselaar, Blandina Mmbaga and 1 more

Abstract read
In one paragraph

Article in BMC genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. High-qualityMicrobiology spectrum · 2026
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masoud A JumaKilimanjaro Christian Medical University College (KCMUCo), Kilimanjaro, Tanzania. sallass2012@gmail.com.
Happiness KumburuKilimanjaro Christian Medical University College (KCMUCo), Kilimanjaro, Tanzania.
Boaz WaduguKilimanjaro Christian Medical University College (KCMUCo), Kilimanjaro, Tanzania.
Davis KuchakaKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Mariana ShayoKilimanjaro Christian Medical University College (KCMUCo), Kilimanjaro, Tanzania.
Patrick KimuKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Livin E KanjeKilimanjaro Christian Medical University College (KCMUCo), Kilimanjaro, Tanzania.
Melkiory BetiKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Marco van ZwetselaarKilimanjaro Clinical Research Institute, Kilimanjaro, Tanzania.
Blandina MmbagaKilimanjaro Christian Medical University College (KCMUCo), Kilimanjaro, Tanzania.
Tolbert SondaKilimanjaro Christian Medical University College (KCMUCo), Kilimanjaro, Tanzania.

Funding

Danida Fellowship Centre No. 20-12-TAN
6 · The paper itself

Abstract

backgroundThe emergence of multidrug-resistant termed Methicillin-resistant Staphylococcus aureus (MRSA) strain, driven by the acquisition of resistance gene mecA imposes a substantial challenge in the treatment and control of their related infections. Although quinolones have historically been effective against both MRSA and methicillin-susceptible S. aureus (MSSA) strains, the rising resistance to quinolones among S. aureus isolates, particularly in MRSA, has severely curtailed their potency and further narrowed down the therapeutic options. This study aimed to determine the burden of MRSA among isolates, as well as their resistance profile, genotypic characterization, and molecular relatedness through the construction of a phylogenetic tree. MATERIALS AND

methodsArchived clinical S. aureus isolates from a descriptive, cross-sectional study involving six regional referral hospitals in Dodoma, Songea, Kigoma, Kitete, and Morogoro in the mainland Tanzania and Mnazi Mmoja in Zanzibar were analyzed. Bacterial identification was performed using both classical microbiology and whole genome sequencing on Illumina Nextseq 550 Sequencer. Species identification was done using KmerFinder 3.2, Multilocus Sequence Typing using MLST 2.0, SCCmec typing using SCCmecFinder 1.2, resistance genes using ResFinder 4.1, and phylogenetic relatedness using CSI Phylogeny 1.4.

resultsOut of the 140 isolates analyzed, 69 (49.3%) were identified as MRSA, with 57 (82.6%) exhibiting quinolone resistance. Conversely, 71 isolates were identified as MSSA, and none of them exhibited resistance to quinolones. Spa-typing revealed six spa types, with t355, t1476, and t498 being the most common. Moreover, all (69) MRSA were found to carry SCCmec type IV. The isolates exhibited 14 different sequence types (STs). Notably, ST152 was prevalent among MSSA (50 isolates, 70%), while ST8 was the predominant sequence type among MRSA (58 isolates, 84%). The antimicrobial resistance profile revealed at least three horizontally acquired resistance genes, with blaZ, dfrG, tet(K), and aac (6')-aph (2'') genes being highly prevalent.

conclusionThere is a high genetic diversity among the S. aureus isolates existing in Tanzania regional hospitals, with a concerning burden of quinolone resistance among MRSA isolates. The diversity in resistance genes among MRSA lineages emphasizes the necessity for the development of sustainable antimicrobial stewardship and surveillance to support evidence-based guidelines for managing and controlling MRSA infections in both community and hospital settings.

Indexed as

Methicillin-Resistant Staphylococcus aureusPhylogenyQuinolonesStaphylococcal InfectionsWhole Genome SequencingAnti-Bacterial AgentsCross-Sectional StudiesDrug Resistance, BacterialHumansMicrobial Sensitivity TestsMultilocus Sequence TypingStaphylococcus aureusTanzaniaAnti-Bacterial AgentsQuinolonesMethicillin-resistant S. Aureus (MRSA)Sequence type (ST)Staphylococcal protein A (spa)Staphylococcus Cassette chromosome mec (SCCmec)

Identifiers

PMID39578734
PMCPMC11583670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.